Zika Virus Biospecimens l Order Online

Zika Virus

Zika Virus Disease (ZVD, ICD-10 A92.5) is an infectious arthropod-borne viral tropical infection spreading through infected mosquitoes of the Aedes genus, primarily Aedes Aegypti and Aedes albopictus. It is a specific flavivirus infection caused by Zika Virus (ZIKV) infecting humans predominantly in tropical and sub-tropical areas and is greatly influenced by climatic changes. Despite this, the Zika virus can be sexually transmitted, possibly through body fluids and during a blood transfusion. Moreover, Zika virus infection can cause serious CNS or neurological complications, congenital anomalies in newborns, and Guillain-Barre syndrome (GBS). The lack of licensed vaccination and definitive antiviral therapy evokes public health concerns in Zika endemic regions. All efforts for the development of a novel vaccination and pharmacological treatment are still in the trial phase. However, prevention of disease is possible by effective mosquito control measures and protection against mosquito bites. Explore advanced search options by clicking CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS.

Show rows
|< < of > >|

Clinical Presentation of Zika Virus Disease:

Signs and symptoms of Zika virus infection are generally milder and self-limiting. Although most of the patients stay asymptomatic in the early infection phase experiencing a mild fever when presented. However, in later stages, the patient experiences high-grade fever, malaise, headache, arthralgia, myalgia, conjunctivitis, and maculopapular rashes.
The Zika virus' teratogenicity causes detrimental implications on pregnant women, leading to the fetal demise or causing congenital CNS malformations and microcephaly.


Clinical Diagnosis of Zika Virus Disease :

Besides exposure history to Zika endemic regions, clinical presentations, examination of body fluids like urine, saliva, tissues, and whole blood of the infected individual for the presence of Virus RNA can be helpful in the initial diagnosis of Zika infection. While in later infection stages, serological testing is performed to detect anti-Zika virus IgM antibodies to confirm viral infection.


Insight to the Zika Virus Disease Biospecimens We Offer:

Central BioHub offers no compromise to genuine biospecimens isolated using the most hygienic and advanced clinical diagnostic methodologies. Our biobank supplies authentic, superior quality biospecimens ethically derived from voluntary donors of every age, gender, and ethnicity that complies with the mandatory standards and declarations.
The human biospecimens of Zika disease such as saliva, whole blood, urine, plasma, and serum samples are obtained from suspected or infected patients screened and tested authentically in certified laboratories. Every Zika virus samples we offer is accurately measured for Zika virus IgG and IgM by molecular methods like immunoassay and MAC-ELISA to yield diagnostic specificity and sensitivity. Moreover, focusing on accelerating innovative clinical research and drug discovery processes, Central BioHub offers Zika infection samples, hyper-annotated with clinical data and geographical area of sample origin to support tropical research.
To better reach the scientific advancements and biomedical research, Central BioHub always has options of pristine zika virus biospecimens in predefined volumes stored under perfect conditions to conserve the inherent properties needed for the successful establishment of the investigation. Therefore, our biorepository stores every available Zika test samples at <-18 or <-80 °C with strict maintenance and avoidance of cross-contamination.
We are none other than a group of scientific enthusiasts looking forward to contributing towards the betterment of life science discovery and global biospecimen supply. Customer satisfaction and quality services are our priorities. Reach out to us to procure the most authentic biospecimens for tropical medicine and infectious disease research.

Zika disease is a mosquito-borne infectious fever caused by the Zika virus (ZIKV). It is spread to humans through the bite of infected Aedes mosquitos. It is usually a self-limiting illness with mild symptoms lasting for many weeks. However, viral infection during pregnancy can lead to severe implications, including congenital disabilities and fetal death.
Presently, no specific vaccination or chemotherapy available for treating Zika virus infection. However, current treatment modalities focus on symptomatic therapy, such as administering acetaminophen or paracetamol for pain and fever. In most cases, Zika infection is mild and self-limiting. Therefore, plenty of rest and fluid intake can improve the patients condition.
Presently, there is no approved preventive vaccination available for Zika virus infection. However, Zika virus infection can be effectively prevented by the following measures to avoid the infected mosquito bite. ? Avoid travelling to Zika-endemic areas. ? Avoid sexual intercourse with Zika infected patients. ? Avoid getting pregnant if you are Zika infected. ? Use mosquito repellents to prevent mosquito bites. ? Cover your body as much as possible by wearing long-sleeved shirts and pants to avoid mosquito bites. ? Use air conditioning and avoid opening doors and windows to abstain from mosquitoes entry into the house. ? Sleep under mosquito nets. ? Avoid stagnant water where mosquitoes can breed.
Zika infection samples are human saliva, urine, whole blood, serum, and plasma samples collected from Zika patients. Yielding diagnostic specificity and sensitivity, Zika fever samples are critically examined for anti-Zika IgM (ZIKM) by molecular methods like immunoassay and MAC-ELISA and cryogenically stored at our biobank.